Autonomix Medical, Inc. Common Stock (AMIX) Valuation
Historical valuation analysis based on 683 data points (2024-01-29 to 2026-10-16)
Autonomix Medical Inc is a development-stage medical device company focused on advancing technologies for sensing and treating disorders of the nervous system. Its platform is designed to integrate...
Autonomix Medical, Inc. Common Stock trades near its historical valuation range, with most metrics close to their median levels.
Historical Valuation Metrics
| Metric | Current | Median | %ile | Assessment |
|---|
Autonomix Medical, Inc. Common Stock (AMIX) Valuation & P/E History
Autonomix Medical, Inc. Common Stock (AMIX) is a US-listed stock operating in the Healthcare sector, specifically the Surgical & Medical Instruments & Apparatus industry currently trading at $2.87 with a market capitalization of $0.0 billion. This page provides historical valuation analysis for AMIX based on 683 data points covering 2024-01-29 to 2026-10-16...
AMIX Valuation Metrics & Historical Range
The valuation table above shows Autonomix Medical, Inc. Common Stock's current and historical valuation multiples, including P/E ratio, P/S ratio, EV/EBITDA, FCF yield, and dividend yield. Each metric is compared to its own historical range to determine whether AMIX is currently trading above or below its typical valuation levels.
- P/E ratio: Price-to-earnings measures how much investors pay per dollar of earnings. A P/E above the historical median suggests AMIX is expensively valued; below the median suggests it is cheap.
- P/S ratio: Price-to-sales is useful for companies with volatile or negative earnings. Lower P/S relative to history may indicate value.
- EV/EBITDA: Enterprise value to EBITDA adjusts for debt and cash, providing a capital-structure-neutral valuation measure for Autonomix Medical, Inc. Common Stock.
- FCF yield: Free cash flow yield shows the cash return relative to market price. Higher yields may indicate undervaluation.
Is AMIX Overvalued or Undervalued?
Autonomix Medical, Inc. Common Stock trades near its historical valuation range, with most metrics close to their median levels. The overall valuation percentile of 50 combines P/E, P/S, and EV/EBITDA percentiles into a single measure of how expensive AMIX is relative to its own history. A percentile below 25 suggests the stock may be undervalued, while a percentile above 75 suggests it may be overvalued.
However, valuation is only one factor in investment decisions. A stock can remain "overvalued" for years if growth accelerates, or "undervalued" if the business deteriorates. Always combine valuation analysis with financial statement analysis and the full AMIX analysis page for a complete picture.
Valuation data is computed from historical price and fundamental data via Polygon.io and Finnhub.AMIX trades on NYSE/NASDAQ. This page is for informational purposes only and is not financial advice.